294 related articles for article (PubMed ID: 26577510)
21. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
22. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
23. Treatment of refractory prurigo nodularis with lenalidomide.
Kanavy H; Bahner J; Korman NJ
Arch Dermatol; 2012 Jul; 148(7):794-6. PubMed ID: 22801610
[No Abstract] [Full Text] [Related]
24. A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis.
Lim VM; Maranda EL; Patel V; Simmons BJ; Jimenez JJ
Dermatol Ther (Heidelb); 2016 Sep; 6(3):397-411. PubMed ID: 27289372
[TBL] [Abstract][Full Text] [Related]
25. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis.
Ferrándiz C; Carrascosa JM; Just M; Bielsa I; Ribera M
Dermatology; 1997; 195(4):359-61. PubMed ID: 9529557
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial.
Silva SR; Viana PC; Lugon NV; Hoette M; Ruzany F; Lugon JR
Nephron; 1994; 67(3):270-3. PubMed ID: 7936015
[TBL] [Abstract][Full Text] [Related]
27. NK-1 Antagonists and Itch.
Ständer S; Luger TA
Handb Exp Pharmacol; 2015; 226():237-55. PubMed ID: 25861784
[TBL] [Abstract][Full Text] [Related]
28. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease.
Gonçalves F
Am J Hosp Palliat Care; 2010 Nov; 27(7):486-7. PubMed ID: 20231735
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.
Siepmann D; Lotts T; Blome C; Braeutigam M; Phan NQ; Butterfass-Bahloul T; Augustin M; Luger TA; Ständer S
Dermatology; 2013; 227(4):353-60. PubMed ID: 24281309
[TBL] [Abstract][Full Text] [Related]
31. Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo.
Estrada-G I; Garibay-Escobar A; Núñez-Vázquez A; Hojyo-Tomoka T; Vega-Memije E; Cortés-Franco R; Pérez-Uribe A; Flores-Romo L; Santos-Argumedo L; Estrada-Parra S; Domínguez-Soto L
Int J Dermatol; 2004 Dec; 43(12):893-7. PubMed ID: 15569010
[TBL] [Abstract][Full Text] [Related]
32. Treatment of prurigo nodularis with topical capsaicin.
Ständer S; Luger T; Metze D
J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide's tightly controlled "comeback".
Calabrese LH
Cleve Clin J Med; 1999 Mar; 66(3):136-8. PubMed ID: 10079581
[TBL] [Abstract][Full Text] [Related]
34. Thalidomide and its dermatologic uses.
Paghdal KV; Schwartz R
Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of chronic itch in systemic disease. Current standards].
Mettang T; Ständer S; Kremer AE
Internist (Berl); 2015 Dec; 56(12):1369-78. PubMed ID: 26585238
[TBL] [Abstract][Full Text] [Related]
36. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
37. Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Ständer S; Kwon P; Hirman J; Perlman AJ; Weisshaar E; Metz M; Luger TA;
J Am Acad Dermatol; 2019 May; 80(5):1395-1402. PubMed ID: 30894279
[TBL] [Abstract][Full Text] [Related]
38. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
[TBL] [Abstract][Full Text] [Related]
39. Long-term thalidomide for actinic prurigo.
Yong-Gee SA; Muir JB
Australas J Dermatol; 2001 Nov; 42(4):281-3. PubMed ID: 11903163
[TBL] [Abstract][Full Text] [Related]
40. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
Shetty K
Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
